Translating genetic insights into medicines
Maze Therapeutics is translating novel genetic insights into lifesaving medicines, through an approach that integrates human genetics and functional genomics. Advances in these areas have enabled Maze and its founders to decode the mysteries of genetic modifiers in a range of severe diseases, which the company aims to turn into medicines that mimic protective modifiers. Maze has assembled a world-class team needed in order to realize this vision, including creative scientific pioneers in genetics, experienced company builders, and biotech industry leaders.
Year Invested: 2019